Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis

Archive ouverte

Nambot, Sophie | Thévenon, Julien | Kuentz, Paul | Duffourd, Yannis | Tisserant, Emilie | Bruel, Ange-Line | Mosca-Boidron, Anne-Laure | Masurel-Paulet, Alice | Lehalle, Daphné | Jean-Marçais, Nolwenn | Lefebvre, Mathilde | Vabres, Pierre | El Chehadeh-Djebbar, Salima | Philippe, Christophe | Tran Mau-Them, Frederic | St-Onge, Judith | Jouan, Thibaud | Chevarin, Martin | Poe, Charlotte | Carmignac, Virginie | Vitobello, Antonio | Callier, Patrick | Rivière, Jean-Baptiste | Faivre, Laurence | Thauvin-Robinet, Christel

Edité par CCSD ; Nature Publishing Group -

International audience. PurposeCongenital anomalies and intellectual disability (CA/ID) are a major diagnostic challenge in medical genetics—50% of patients still have no molecular diagnosis after a long and stressful diagnostic “odyssey.” Solo clinical whole-exome sequencing (WES) was applied in our genetics center to improve diagnosis in patients with CA/ID.MethodsThis retrospective study examined 416 consecutive tests performed over 3 years to demonstrate the effectiveness of periodically reanalyzing WES data. The raw data from each nonpositive test was reanalyzed at 12 months with the most recent pipeline and in the light of new data in the literature. The results of the reanalysis for patients enrolled in the third year are not yet available.ResultsOf the 416 patients included, data for 156 without a diagnosis were reanalyzed. We obtained 24 (15.4%) additional diagnoses: 12 through the usual diagnostic process (7 new publications, 4 initially misclassified, and 1 copy-number variant), and 12 through translational research by international data sharing. The final yield of positive results was 27.9% through a strict diagnostic approach, and 2.9% through an additional research strategy.ConclusionThis article highlights the effectiveness of periodically combining diagnostic reinterpretation of clinical WES data with translational research involving data sharing for candidate genes.

Consulter en ligne

Suggestions

Du même auteur

Reducing diagnostic turnaround times of exome sequencing for families requiring timely diagnoses

Archive ouverte | Bourchany, Aurélie | CCSD

IF 2.137. International audience. BACKGROUND AND OBJECTIVE:Whole-exome sequencing (WES) has now entered medical practice with powerful applications in the diagnosis of rare Mendelian disorders. Although the usefulne...

Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests

Archive ouverte | Thauvin-Robinet, Christel | CCSD

International audience. With exome/genome sequencing (ES/GS) integrated into the practice of medicine, there is some potential for reporting incidental/secondary findings (IFs/SFs). The issue of IFs/SFs has been stu...

Second-tier trio exome sequencing after negative solo clinical exome sequencing: an efficient strategy to increase diagnostic yield and decipher molecular bases in undiagnosed developmental disorders

Archive ouverte | Mau-Them, Frédéric Tran | CCSD

International audience. Developmental disorders (DD), characterized by malformations/dysmorphism and/or intellectual disability, affecting around 3% of worldwide population, are mostly linked to genetic anomalies. D...

Chargement des enrichissements...